Biblio
STAT3 inhibitor BBI608 reduces patient-specific primary cell viability of cervical and endometrial cancer at a clinical-relevant concentration. Clin Transl Oncol. 2022.
Efficacy of the induced pluripotent stem cell derived and engineered CD276-targeted CAR-NK cells against human esophageal squamous cell carcinoma. Front Immunol. 2024;15:1337489.
Efficacy of MUC1-targeted CAR-NK cells against human tongue squamous cell carcinoma. Front Immunol. 2024;15:1337557.